Drug intelligence / Profile preview

n-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1h-pyrazol-4-yl)-2,5-difluorobenzamide

Development stage
Preclinical
Lead developer
Periyar University
Modality
Small Molecules
01

Overview

N-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-2,5-difluorobenzamide, also known as compound 2 in its primary study, is a fluorescent small molecule synthesized by the condensation of 2,5-difluorobenzoyl chloride and 4-aminoantipyrine. Developed by researchers at Periyar University and C. Abdul Hakeem College of Engineering & Technology, this compound has been investigated for its potential anticancer properties. In vitro studies using an MTT assay demonstrated cytotoxic activity against human cervical cancer cells (SiHa). Molecular docking studies suggest that the molecule interacts with the E7 oncoprotein of Human Papillomavirus 16 (HPV16), which is a key protein in the development and progression of cervical cancer.

Other names
4-aminoantipyrine derivativefluorescent 4-aminoantipyrine analoguefluorescent4-aminoantipyrine analoguefluorescent-4-aminoantipyrine analogue
02

Targets

HPV16 E7 (Human papillomavirus 16 E7 protein)

Beyond the preview

Go deeper on n-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1h-pyrazol-4-yl)-2,5-difluorobenzamide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on n-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1h-pyrazol-4-yl)-2,5-difluorobenzamide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call